2. Effectiveness (VE) vs symptomatic infection over time and, in age 80+, difference dose in spacing (<4 weeks vs 8+ weeks) Note for AZ drop in VE is to < 50% at >5 months pic.twitter.com/fPERx8GmHT— Eric Topol (@EricTopol) September 14, 2021
2. Effectiveness (VE) vs symptomatic infection over time and, in age 80+, difference dose in spacing (<4 weeks vs 8+ weeks) Note for AZ drop in VE is to < 50% at >5 months pic.twitter.com/fPERx8GmHT